BioCryst Pharmaceuticals Inc.  – NasdaqGS: BCRX

Let’s start with the chart for BCRX:

bcrx-ONEYEAR

Normally I look at a chart like that and run. The stock was less than two bucks just six weeks ago and now it is over $6.  From it’s June low to its August high this stock was up 360%. That’s incredible for a NasdaqGS stock. Let’s look at why it did that and – more importantly – why we would ever consider it at the current level of $6.38.

Let’s start with a board member buying five million (and two) dollars worth of BCRX on August 2nd as part of the Company’s offering that closed on August 6th. One of hte reasons I like this buy so much is that this insider is paying about three times the price the stock was trading just weeks ago. While he could have certainly bought back then in the market, he was willing to pay the $4.40 price.  He dropped a hefty sum of $5,000,002 for this purchase. (Source is at end of the article.)

Another reason – Let’s quote from the August 8th press release from BCRX:

 

 

SEE BCRX IN STOCKGURU’S 12 BIOTECH BREAKOUT STOCKS

SEE THE ENTIRE LIST OF STOCKGURU’S 12 BIOTECH BREAKOUT STOCKS 

12-BIOTECH